Clinacox™ and BMD®
Veterinary medicine · U.S. Food and Drug Administration, Center for Veterinary Medicine · United States
-
Animal drug application
141153 -
Animal drug product ID
310
What the source publishes
- Holder
- Elanco US Inc.
- Active ingredients
- Bacitracin methylenedisalicylate Diclazuril
- Form
- Medicated Feed
- Routes
- Oral
- Supply regime
- OTC
Names this record is found by
Complete source data
{
"form": "Medicated Feed",
"name": "Clinacox™ and BMD®",
"holder": "Elanco US Inc.",
"routes": [
"Oral"
],
"smpcUrl": null,
"marketed": null,
"useDomain": "veterinary",
"leafletUrl": null,
"supplyRegime": "OTC",
"nativeProduct": {
"routes": [
"Oral"
],
"species": {
"Chickens:430": "Broilers not laying eggs for human consumption"
},
"sortOrder": 0,
"withdrawals": [
"<p>No withdrawal period is required when used according to labeling. Do not feed to birds producing eggs for human consumption.</p>"
],
"doseFormName": "Medicated Feed",
"applicationId": null,
"specifications": "Diclazuril: Type A medicated article in a concentration of 0.91 grams diclazuril activity per pound. \r\nBacitracin methylene disalicylate: Type A medicated article in concentrations of 10, 25, 30, 50, 60, or 75 grams of bacitracin activity per pound.",
"proprietaryName": "Clinacox™ and BMD®",
"proprietaryNameId": 310,
"statusDescription": "OTC"
},
"nativeSummary": {
"noohDate": null,
"publishDate": "2020-07-17",
"sponsorName": "Elanco US Inc.",
"applicationId": 253,
"applicationType": "N",
"proprietaryName": "Clinacox™ and BMD®\n",
"applicationNumber": 141153,
"activeIngredientName": "Bacitracin methylenedisalicylate\nDiclazuril\n",
"applicationStatusCode": "A",
"applicationStatusValue": null,
"voluntaryWithdrawalDate": null
},
"targetSpecies": [
{
"code": "430",
"label": "Chickens",
"native": {
"key": "Chickens:430",
"population": "Broilers not laying eggs for human consumption"
},
"sourceId": "us.fda.animal-drugs",
"population": "Broilers not laying eggs for human consumption",
"canonicalId": "chicken",
"mappingStatus": "mapped",
"mappingVersion": 1
}
],
"informationUrl": "https://animaldrugsatfda.fda.gov/adafda/views/#/search",
"ingredientScope": "application-level; no product-specific composition inferred",
"nativePublishDate": "2020-07-17",
"sourceDisposition": "reviewed-veterinary-application-product",
"useDomainEvidence": {
"basis": "publisher-dataset-scope",
"field": "sourceId",
"value": "us.fda.animal-drugs",
"version": 1,
"sourceId": "us.fda.animal-drugs"
},
"withdrawalPeriods": [
{
"native": "<p>No withdrawal period is required when used according to labeling. Do not feed to birds producing eggs for human consumption.</p>",
"status": "unparsed"
}
],
"patientEligibility": "not-assessed",
"nativeApplicationId": 253,
"targetSpeciesStatus": "reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "unknown",
"activeIngredientsText": "Bacitracin methylenedisalicylate\nDiclazuril\n",
"nativeApplicationType": "N",
"applicationIngredients": [
{
"activeIngredientName": "Diclazuril",
"activeIngredientTolerance": "<p>(1) Chickens</p>\r\n<p>(i) Liver. The tolerance for parent diclazuril (the marker residue) is 3 parts per million (ppm).</p>\r\n<p>(ii) Muscle. The tolerance for parent diclazuril (the marker residue) is 0.5 ppm.</p>\r\n<p>(iii) Skin/fat. The tolerance for parent diclazuril (the marker residue) is 1 ppm.</p>\r\n<p>(2) Turkeys</p>\r\n<p>(i) Liver. The tolerance for parent diclazuril (the marker residue) is 3 ppm.</p>\r\n<p> (ii) Muscle. The tolerance for parent diclazuril (the marker residue) is 0.5 ppm.</p>\r\n<p> (iii) Skin/fat. The tolerance for parent diclazuril (the marker residue) is 1 ppm.</p>"
},
{
"activeIngredientName": "Bacitracin methylenedisalicylate",
"activeIngredientTolerance": null
}
],
"nativeApplicationNumber": 141153,
"nativeProprietaryNameId": 310,
"restrictionObservations": [
{
"indicationText": "For the prevention of coccidiosis caused by <i>Eimeria necatrix</i>, <i>E. tenella</i>, <i>E. acervulina</i>, <i>E. brunetti</i>, <i>E. mitis</i> (<i>mivati</i>), and <i>E. maxima</i>. Because diclazuril is effective against <i>E. maxima</i> later in its life cycle, subclinical intestinal lesions may be present for a short time after infection. Diclazuril was shown in studies to reduce lesion scores and improve performance and health of birds challenged with <i>E. maxima</i>. For increased rate of weight gain and improved feed efficiency in broiler chickens.",
"limitationText": null,
"populationText": "Broiler Chickens"
}
],
"withdrawalPeriodsStatus": "reported-unparsed",
"publisherIdentityMeaning": "applicationId/proprietaryNameId are technical website keys; applicationNumber is a separate FDA application reference",
"nativeNoticeOfHearingDate": null,
"nativeApplicationStatusCode": "A",
"nativeVoluntaryWithdrawalDate": null
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.animal-drugs" \
--data-urlencode "id=us:fda:animaldrugs:253:310"